<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878841/" ref="ordinalpos=2606&amp;ncbi_uid=3082254&amp;link_uid=PMC2878841" image-link="/pmc/articles/PMC2878841/figure/F2/" class="imagepopup">Fig. 2.  From: Disruption of IGF-1R <span class="highlight" style="background-color:">signaling</span> increases TRAIL-induced apoptosis: a new potential therapy for the treatment of melanoma. </a></div><br /><div class="p4l_captionBody">Effects of PPP on IGF-1-mediated signaling pathway in melanoma cells. A–C. Western blot analysis was performed 4–24 h after treatment of WM35 and WM9 or LU1205 and WM793 melanoma cells with indicated doses of PPP. Analyzed proteins are indicated.</div></div>